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A novel series of 1-[(substituted 2-chloroquinolin-3-yl)methylidene]-3-[substituted-5-phenyl-1,3,4-thiadiazol-2-yl] thioureas 
have been synthesized by acid catalyzed reaction between the 1-(5-substitued phenyl-1,3,4-thiadiazol-2-yl) thioureas and 
6-substituted-2-chloro-3-formyl quinolines. The structures of these compounds have been confirmed by spectral techniques
like IR, 1H NMR and mass spectroscopy. The new compounds have been screened for their antibacterial and antifungal
activity studies. Most of the compounds show good activity comparable with that of the standard drugs.
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1,3,4-Thiadiazole moiety have been widely used by 
the medicinal chemist in the past to explore its 
biological activities. The first 1,3,4-thiadiazole was 
described by Fischer in 1882 but the true nature of the 
ring system was demonstrated first in 1890 by Freund 
and Kuh
1
. Members of this ring system have found 
their way in to such diverse applications as 
pharmaceuticals, oxidation inhibitors, cyanide dyes, 
metal complexing agents. During recent years there 
has been intense investigation of different classes of 
thiadiazole compounds, many of which known to 



















 activity. Jumat Saliman 
et al.
10
 synthesized a series of 2-N-salicylidene-5-
(substituted)-1,3,4-thiadiazole as potential antimicrobial 
agents. Hence, this field has ever growing importance 
resulting in the development scores of thiadiazoles. In 
heterocyclic chemistry quinoline derivatives are also 
very useful since they show diverse pharmacological 
properties. The derivatives of quinoline show a 













based fluoroquinolone derivatives were synthesized as 
potential antibacterial and anticancer agents using a 
molecular hybridization approach
16
. New series of 
quinoline-based thiadiazole analogues were synthesized, 
characterized and subjected to their antileishmenial 
potential and molecular docking studies
17
. Synthesis 
and antibacterial, antimycobacterial activity of 7- 
[4-{5- (2-oxo-2-p-substituted-phenylethylthio)-
1,3,4-thiadiazol-2yl}-3′-methylpiperazinyl] quinoline 
derivatives were reported by Kapil et al.
18
 In the 
view of the varied biological and pharmacological 
applications of quinoline and 1,3,4-thiadiazole 
derivatives, we have planned to synthesize some 
1,3,4-thadiazole containing quinoline derivatives and 
study their antibacterial and antifungal activities. 
Results and Discussion 
In the present study, twelve new 1-[(substituted 2-
chloroquinolin-3-yl)methylidene]-3-[substitutued-5-
phenyl-1,3,4-thiadiazol-2-yl] thioureas 5 were 
synthesized by the reaction of 1-(5-substitued phenyl-
1,3,4-thiadiazole-2-yl) thioureas 4 and 6-substituted-
2-chloro-3-formyl quinolines 2 using acetic acid as 
the catalyst (Scheme I). The intermediates, 1-(5-
substitued phenyl-1,3,4-thiadiazole-2-yl) thioureas 4 
were prepared by the reaction of 2-amino-5-
substituted aryl-1,3,4- thiadiazoles 3 and ammonium 
thiocyante in presence of conc. HCl. 2-Amino-5-
substituted aryl-1,3,4- thiadiazoles
19
 3 were prepared 




by the reaction of thiosemicarbazides, substituted 
benzoic acids in the presence of conc. H2SO4 catalyst. 
6-Substituted-2-chloro-3-formyl quinolines
20
 2 were 
prepared by the reaction of substituted acetanilide, 
dimethyl formamide and POCl3 (Scheme I). The 
characterization data of the synthesized compounds 
5a-l was collected and presented in Table I. 
 
Experimental Section 
All the materials used were from Sigma Aldrich, 
Alfa, and Spectrochem Chemicals Pvt. Ltd. Melting 
points of all the synthesised compounds were 
recorded by melting point instrument and are 
uncorrected. The completion of the reaction process 
were checked by TLC. IR spectra were recorded  
on a Nicolet Avatar 330 FTIR spectrophotometer, 
1
H NMR was recorded on Bruker 400 MHz 
spectrometer and mass of the compound was 
determined by LCMS on Shimadzu LCMS 2010A 
instrument. 
 
General procedure for the synthesis of 6- 
substituted-2-chloro-3-formyl quinolines, 2 
To a solution of substituted acetanilide (5 mmol) in 
dry dimethyl formamide (15 mmol) at 0-5°C with 
stirring POCl3 (60 mmol) was added drop-wise and 
the mixture stirred at 80-90°C for time ranging 
between 4-16 h. The product obtained was poured 
into crushed ice, stirred for 5 min and the resulting 
solid mass was filtered, washed well with water and 
dried. The compounds were recrystallized from ethyl 
acetate. 
 
General procedure for synthesis of 2-amino -5- 
substituted aryl -1,3,4- thiadiazoles, 3 
A mixture of thiosemicarbazide (0.01 mol), 
substituted benzoic acid (0.01 mol) and conc. H2SO4 
were refluxed for 2 h and poured into crushed ice.  
The resulting solid was collected by filtration,  











Table I — Characteristic data of 1-[(substituted 2-chloroquinolin-3-yl)methylidene]-3-[substitutued -5-phenyl-1,3,4-thiadiazol-2-yl] 
thioureas 5a-l 
Compd Structure Colour m.p. (°C) Yield (%) Crystallization solvent 
5a 
 
white 192 60 Ethanol 
5b 
 
yellow 230 65 Ethanol + DMF 
5c 
 
orange 172 65 Ethanol 
5d 
 
yellow 190 66 Ethanol 
5e 
 
yellow 256 66 Ethanol + DMF 
5f 
 
yellow 201 63 Ethanol 
5g 
 
white 291 75 Ethanol 
5h 
 
yellow 255 77 Ethanol + DMF 
5i 
 
orange 245 67 Ethanol 
5j 
 
white 267 66 Ethanol 
5k 
 
yellow 269 75 Ethanol + DMF 
5l 
 
orange 257 60 Ethanol 
 




General procedure for synthesis of 1-(5-substitued 
phenyl-1,3,4-thiadiazole-2-yl) thioureas, 4 
A mixture of 2-amino-5-substituted aryl-1,3,4-
thiadiazoles (0.01 mol), ammonium thiocyante (0.02 
mol), conc. HCl (1 mL) and water (20 mL) mixture 
refluxed for 3 h. After cooling, the resulting solid was 
collected by filtration, washed with water, dried and 
recrystallized from ethanol. 
 
General procedure for the synthesis of 1-
[(substituted 2-chloroquinolin-3-yl)methylidene]-3-
[substituted -5-phenyl-1,3,4-thiadiazol-2-yl] thioureas, 
5 
The solution of 1-(5-substitued phenyl-1,3, 
4-thiadiazole-2-yl) thioureas 4 (0.01 mol) and  
6-substituted-2-chloro-3-formyl quinolines (0.01mol) 
in ethanol (100-200 mL) and glacial acetic acid 
(2 mL) was added and refluxed for 16 h. The crude 
product obtained was purified by recrystallization 
from a mixture of ethanol and dimethyl formamide to 
obtain pure crystalline compounds. 
The structures of newly synthesized compounds 5 
have been characterised by FT-IR, 
1
H NMR and  
LC-MS. 
FT-IR spectrum (KBr) of compound 5b showed 
absorption band at 1687 cm
−1
 due to (-CH=N 
stretching), 3268.89 cm
−1
 due to the (N-H stretching) 
and other bands are 2941.54 cm
−1
 (C-H aromatic 
stretching), 1619.93 cm
−1 
(C=C stretching), 1017.65 
cm
−1
(N-N stretching), 647.27 cm
−1











spectrum of compound 5b showed signals at δ 10.45 
(s) belongs to -CH=N proton, 8.5 (s) belongs to NH, 
8.77 (s) belongs to quinoline H-4 proton, 7.7 to  
8.3 (m) belongs quinoline H-5, H-6, H-8 protons and 
7.25 to 7.67 (m) belongs to phenyl ring protons. The 
mass spectrum of the compound 5b showed the 
molecular ion peak at m/z 443, consistent with the 
molecular formula C19H11Cl2 N5S2. 
Similarly FTIR, 
1
H NMR and mass spectra of 
novel compounds 5c, 5h and 5i were recorded and the 
peaks observed are assigned as follows. 
 
5c: FT-IR (KBr): 1687.25 (-CH=N- stretching), 
1617 (C- H stretching), 2868.28 (N-H stretching), 
1617.62 (C=C stretching), 1012.27 (N-N stretching), 
643.77 (C-S-C stretching), 1425.32 (C-N stretching) 
and 1044 cm
−1
 (C-S stretching); 
1
H NMR (DMSO-d6, 
400 MHz): δ 10.5 (s, 1H, CH=N), 8.5 (s, 1H, NH), 
8.62 (s, 1H, quinoline H-4) and 7.17 – 7.95 (m, 8H, 
quinoline, phenyl protons); LC-MS: M
+
 at m/z 454.5 
(Mol. Formula: C19H11ClN6O2S2). 
 
5h: FT-IR (KBr): 1687.96 (–CH=N stretching), 
2866.15 (N-H stretching) 1619.93 (C=C stretching) 
1017.65 (N-N stretching) 764.98 (C-Cl stretching) 
1619.93 (C=C aromatic stretching), 1488.64  
(C-N stretching) and 647.27 cm
−1
 (C-S-C stretching); 
1
H NMR (DMSO-d6, 400 MHz): δ 10.5 (s, 1H, 
CH=N), 7.98 - 8.05 (m, 3H, quinoline protons), 7.20- 
7.51 (m, 4H, phenyl protons), 8.6 (s, 1H, quinoline  
H-4) and 3.95 (s, 3H, OCH3 protons); MS: M
+
 at at 
m/z 473 (Mol. Formula: C20H13Cl2 N5 OS2). 
 
5i: FT-IR (KBr): 1693.46 (CH=N stretching), 
2841.22 (N-H strectching), 1604.11 (C=C stretching), 
715.48 (C-S-C stretching) 799.14 (C-Cl stretching) 
1012.02 (N-N stretching) 1428.03 (C-N stretching) 
and 715.48 cm
−1
 (C-S stretching); 
1
H NMR (DMSO-
d6, 400 MHz): δ 10.5 (s, 1H, CH=N), 7.17-7.95 (m, 
8H, quinoline, N-H and aromatic protons), 8.6 (s, 1H, 
quinoline H-4)) and 3.9 (s, 3H, OCH3 protons); MS: 
M
+
 at m/z 484 (Mol. Formula: C20H13ClN6O3S2). 
 
Antimicrobial activity 
The newly synthesized compounds 5 were tested 
for antibacterial and antifungal activities using 
minimum inhibitory concentration (MIC)
21
 by the 
serial dilution method
22
. The MIC of the antibiotic for 
the organism is determined first. For this, the 
antibiotic is serially diluted in broth. Then a standard 
drop of the culture prepared for the assay is added to 
each of the antibiotic dilutions and incubated for 16–
18 h at 37°C. The MIC is the highest dilution of the 
antibiotic, which shows clear fluid with no 
development of turbidity. The test compound was 
dissolved in dimethylformamide (5 mL) to prepare a 
stock solution of concentration 1000 μg/mL. One loop 
full of an 18 h broth culture was inoculated into 5 mL 
of nutrient broth and this was incubated at 37°C for 
4 h. An assay was prepared by diluting with labelled 
test tubes 1–11. An aliquot having 0.5 mL of stock 
solution test compound was added to the first tube. 
The solution was mixed well and 0.5 mL of this 
solution was transferred into second tube. This 
process was repeated serially to obtain the quantities 
indicated in each of the test tubes. The eleventh test 
tube was taken as growth control. A drop of diluted 
broth culture of the test organism (approximately 
0.5 mL) was added into all the tubes using a sterilized 
Pasteur pipette. The solutions were mixed gently and 




the incubation was carried out at 37°C for 16–18 h. 
Nitrofurazone dissolved in dimethylformamide was 
used as standard drug. The concentration at which 
there was no turbidity was taken as minimum 
inhibitory concentration (MIC) and the results are 
tabulated in Table II. The antibacterial activity study 
of the newly synthesized compounds were carried out 
against two different pathogenic bacteria such  
as Staphylococcus aureus (gram positive) and 
Escherichia coli (gram negative). The majority of the 
compounds displayed moderate to good antibacterial 
activity comparable with that of standard drug 
Nitrofurazone. Among the compounds tested, 5e, 5f, 
5h, 5i and 5l showed significant antibacterial activity 
comparable with that of standard drug. The better 
efficacy of compounds 5e, 5f, 5h, 5i and 5l could be 
due to the presence of the electron-withdrawing 
groups such as –NO2 and –Cl. 
Similarly the antifungal activity study of compounds 
5 was carried out against the two fungi namely 
Aspergillus flavus and Candida albicans using the same 
procedure. Fluconazole was engaged as the standard. 
The results of antifungal activity data are also given in 
Table II. Among the compounds tested, the compounds 
5e, 5f and 5h exhibited the highest antifungal activity 
and all other compounds displayed potent activities 





thioureas 5 were prepared by the condensation of 6/8-
substituted -2-chloro-3-formyl quinoline with 1-(5-
substituted phenyl-1,3,4-thiadiazol-2-yl) thioureas in 
the presence of glacial acetic acid. The products  
were characterized on the basis of their melting point, 
IR, 
1
H NMR and mass spectroscopy. Synthesized 
compounds were screened for their antibacterial and 
antifungal activity. Among the twelve derivative 
compounds tested, most of compounds have shown 
good antibacterial and antifungal activities. 
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